Jones Trading Maintains Buy on Adicet Bio, Lowers Price Target to $4
Portfolio Pulse from Benzinga Newsdesk
Jones Trading analyst Soumit Roy maintains a Buy rating on Adicet Bio (NASDAQ:ACET) but lowers the price target from $6 to $4.
September 11, 2024 | 3:48 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Jones Trading maintains a Buy rating on Adicet Bio but lowers the price target from $6 to $4, indicating a more cautious outlook.
The maintenance of a Buy rating suggests continued confidence in Adicet Bio's potential, but the lowered price target reflects a more cautious outlook, possibly due to market conditions or company performance. This mixed signal may result in a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100